All Biotech News

List of articles in category All Biotech News
Title	Published Date
Kupando Announces First Patient Dosed in Phase 1 Clinical Study of Lead Candidate KUP101 in Advanced Solid Tumors	08/06/2026
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platformv	08/03/2026
Touchlight’s Doggybone™ DNA (dbDNA™) Technology Enables First UK Patient Dosing in Pioneering Personalised Lung Cancer Vaccine Trial	07/30/2026
ProBioGen and VarmX B.V. Announce Collaboration for Advanced Cell Line Development	07/28/2026
Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles	07/28/2026
TSI Receives Turkish Regulatory Authorization to Initiate Phase 2 PROMPT-STEMI Trial	07/24/2026
Lilac Biosciences and Soin Neuroscience Announce Publication of Clinical Review on RNA Biomarkers for Neuropathic Pain	07/23/2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years	07/21/2026
HEALEY ALS Platform Trial Regimen I Enrolment Completed - Topline Results for NUZ-001 Accelerated to Q2 CY2027	07/17/2026
AlphaRose Therapeutics Announces “N-of-1” Drug Repurposing Platform for Rare Sanfilippo B Syndrome	07/16/2026
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies	07/09/2026
Abcam and EpiCypher Partner to Deliver Faster, High-Confidence Epigenomic Insights with Validated Antibodies and ChIC/CUT&RUN Technology	07/07/2026
OECD Publishes Test Guideline for ToxTracker®	07/06/2026
BioMed X Launches Innovation Circle at BIO International Convention 2026	07/02/2026
Navigo Proteins Appoints Dr. Florian Settele as Managing Director of Navigo Pure	07/01/2026
Telum Therapeutics Secures €18 Million Series A Financing to Advance Lead Antimicrobial Program into Clinical Development	07/01/2026
ModeX COVID-19 Antibody Enters Phase I Developed on ProBioGen's Transposase Technology	06/30/2026
Icosagen Completes €45 Million Expansion, Bringing Therapeutic Protein Discovery, Development and GMP Manufacturing Together Under One Roof	06/30/2026
BioMed X Launches Global Call for Research Proposals in Neural Circuit Regulation of Immune Function	06/23/2026
Neurizon Executes Long-Term Supply Agreement with Elanco Strengthening Commercialisation Readiness	06/17/2026
Single Use Support Launches Next-Generation Controlled-Rate Blast Freezer	06/17/2026
HEALEY ALS Platform Trial Surpasses 50% Dosing Milestone Ahead of Schedule	06/12/2026
Ryvu Therapeutics Presents Clinical Data and Program Update on Romaciclib at the European Hematology Association Congress 2026	06/11/2026
T-CURX Non-Viral Siglec-6 Lead CAR-T Program, TCX-001, Was Approved for First-In-Human Phase 1 Clinical Trial in Patients with Relapsed/Refractory AML and CLL	06/11/2026
AOP Health Targets Challenging Blood Cancers with First-In-Class Therapy	06/08/2026
Haga Bioscience Raises $2.3M in Oversubscribed Seed Round to Bridge Spatial Biomarker Discovery and Clinical Translation	06/03/2026
T-CURX Acquires Pantherna Therapeutics to Accelerate Clinical Translation of its Non-Viral In Vivo CAR-T Strategies	06/01/2026
International Research Focuses on Deuterium Depletion – Hungarian Scientific Discovery May Bring a Paradigm Shift in the Treatment of Chronic Diseases	05/29/2026
HEALEY ALS Platform Trial Regimen I Expands to 240 Participants	05/27/2026
ProBioGen Launches AGE1.CR.ReX Designer Cell Line for High-Titer Poxvirus Production	05/27/2026

Page 1 of 88

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End